title: Clinical and microbiological characteristics of Klebsiella pneumoniae from community-acquired recurrent urinary tract infections.
abstract: Understanding the pathogenesis of recurrent urinary tract infection (RUTI) and whether it is attributable to reinfection with a new strain or relapse with the primary infecting strain is of considerable importance. Because previous studies regarding community-acquired Klebsiella pneumoniae RUTI are inconclusive, we undertook this study to evaluate the characteristics of the host and the bacterial agent K. pneumoniae in RUTI. A prospective study was designed, using consecutive patients diagnosed with community-acquired K. pneumoniae-related UTI from January 2007 to December 2009. Of the total 468 consecutive episodes, we found 7 patients with RUTI. All the patients with RUTI were elderly (median, 74 years), with diabetes (100 %, 7 out of 7). Clinical K. pneumoniae isolates derived from the same patients with RUTI revealed identical genomic fingerprints, indicating that K. pneumoniae UTI relapsed despite appropriate antibiotic therapy. The antimicrobial resistance, growth curve and biofilm formation of the recurrent isolates did not change. K. pneumoniae strains causing RUTI had more adhesion and invasiveness than the colonization strains (p < 0.01). When we compared the recurrent strains with the community-acquired UTI strains, the prevalence of diabetes mellitus was significant (100 % vs 53.7 %, p = 0.03) in the RUTI group. Our data suggest that K. pneumoniae strains might be able to persist within the urinary tract despite appropriate antibiotic treatment, and the greater adhesion and invasiveness in the recurrent strains may play an important role in recurrent infections.
authors.affiliation: Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
authors.forename: W H
authors.initials: WH
authors.lastname: Lin
authors.forename: C Y
authors.initials: CY
authors.lastname: Kao
authors.forename: D C
authors.initials: DC
authors.lastname: Yang
authors.forename: C C
authors.initials: CC
authors.lastname: Tseng
authors.forename: A B
authors.initials: AB
authors.lastname: Wu
authors.forename: C H
authors.initials: CH
authors.lastname: Teng
authors.forename: M C
authors.initials: MC
authors.lastname: Wang
authors.forename: J J
authors.initials: JJ
authors.lastname: Wu
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018441:Biofilms / Q000254:growth & development; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology*; D016172:DNA Fingerprinting; D024881:Drug Resistance, Bacterial; D005260:Female; D005838:Genotype; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy / Q000382:microbiology*; D007711:Klebsiella pneumoniae / Q000145:classification / Q000235:genetics / Q000302:isolation & purification* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D058889:Molecular Typing; D011446:Prospective Studies; D012008:Recurrence; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology*
references.citation: Am J Kidney Dis. 2005 Sep;46(3):432-9
references.pmid: 16129204
references.citation: Infect Immun. 2002 Mar;70(3):1075-80
references.pmid: 11854185
references.citation: J Clin Microbiol. 2009 Oct;47(10):3161-9
references.pmid: 19710271
references.citation: Med Microbiol Immunol. 2013 Apr;202(2):105-15
references.pmid: 22797522
references.citation: J Infect. 2007 Jul;55(1):8-18
references.pmid: 17331583
references.citation: Clin Infect Dis. 2006 May 15;42(10):1351-8
references.pmid: 16619144
references.citation: Rev Infect Dis. 1991 Jan-Feb;13(1):77-84
references.pmid: 2017637
references.citation: Infect Immun. 2008 Sep;76(9):4055-65
references.pmid: 18559432
references.citation: J Exp Med. 2004 Mar 1;199(5):697-705
references.pmid: 14993253
references.citation: Am J Public Health. 1990 Mar;80(3):331-3
references.pmid: 2305919
references.citation: N Engl J Med. 1966 Jul 14;275(2):70-3
references.pmid: 5327811
references.citation: Clin Infect Dis. 1996 Jan;22(1):91-9
references.pmid: 8824972
references.citation: Infection. 2010 Dec;38(6):459-64
references.pmid: 20734217
references.citation: Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S54-7
references.pmid: 18054467
references.citation: Cell. 1993 Jun 4;73(5):903-20
references.pmid: 8500180
references.citation: Diabetes Care. 2002 Oct;25(10):1778-83
references.pmid: 12351477
references.citation: J Infect Dis. 2009 Aug 15;200(4):528-36
references.pmid: 19586416
references.citation: Infect Immun. 1998 Apr;66(4):1460-6
references.pmid: 9529068
references.citation: Clin Infect Dis. 2005 Aug 1;41(3):281-8
references.pmid: 16007521
references.citation: Cochrane Database Syst Rev. 2004;(3):CD001209
references.pmid: 15266443
references.citation: Infect Immun. 1997 Jul;65(7):2950-8
references.pmid: 9199471
references.citation: N Engl J Med. 2003 Jan 16;348(3):195-202
references.pmid: 12529459
references.citation: J Bacteriol. 2009 Mar;191(6):1941-50
references.pmid: 19151141
references.citation: Pediatr Nephrol. 2003 Apr;18(4):362-5
references.pmid: 12700963
references.citation: Can Urol Assoc J. 2011 Oct;5(5):316-22
references.pmid: 22031610
references.citation: Clin Infect Dis. 2007 Aug 1;45(3):284-93
references.pmid: 17599305
references.citation: Infect Immun. 2002 Mar;70(3):1225-9
references.pmid: 11854204